Article

Prevalence and Clinical Implications of Somatic and Germline EGFR Mutations in Patients with Non-Small Cell Lung Cancer

2026-07-03

Abstract excerpt

Epidermal growth factor receptor (EGFR)-targeted therapy represents the first and most successful example of precision oncology in non–small cell lung cancer (NSCLC), with more than 10 approved agents, including tyrosine kinase inhibitors, bispecific antibodies and antibody–drug conjugates. Over the past two decades, the diagnostic and therapeutic landscape of EGFR-mutant NSCLC has evolved from empiric treatment t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 648edd35-ca68-5d14-a625-98798207fe5b
DOI: 10.20944/preprints202607.0213.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prevalence and Clinical Implications of Somatic and Germline EGFR Mutations in Patients with Non-Small Cell Lung CancerDOI 10.20944/preprints202607.0213.v1Read

Germline EGFR Mutations and Familial Lung Cancer.Semantic proximity Read

The role of germline mutations in non-small cell lung cancer: A systematic review of emerging genetic drivers and clinical implications.Semantic proximity Read

Molecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Semantic proximity Read

EGFR-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine: Importance of Germline EGFR T790M Testing.Semantic proximity Read

Germline EGFR mutations in lung cancer (Review)Semantic proximity Read

Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer.Semantic proximity Read

The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality.Semantic proximity Read

Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancerSemantic proximity Read

The expanding capability and clinical relevance of molecular diagnostic technology to identify and evaluate EGFR mutations in advanced/metastatic NSCLC.Semantic proximity Read

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.Semantic proximity Read

EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.Semantic proximity Read

Biological and therapeutic implications of the cancer-related germline mutation landscape in lung cancer.Semantic proximity Read